Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
16
UHG Quote, Financials, Valuation and Earnings
Last price:
$4.21
Seasonality move
:
-0.73%
Day range:
$4.11 - $4.35
52-week range:
$4.01 - $9.48
Dividend yield:
0%
P/E ratio:
3.18x
P/S ratio:
0.56x
P/B ratio:
10.30x
Volume:
83.1K
Avg. volume:
62K
1-year change:
-43.79%
Market cap:
$203.8M
Revenue:
$421.5M
EPS (TTM):
-$0.59
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $272.2M | $327.3M | $432.9M | $477M | $421.5M | |
| Revenue Growth (YoY) | -- | 20.21% | 32.28% | 10.2% | -11.65% | |
| Cost of Revenues | $217.1M | $260.1M | $332.3M | $358.2M | $341.7M | |
| Gross Profit | $55.1M | $67.1M | $100.6M | $118.8M | $79.7M | |
| Gross Profit Margin | 20.25% | 20.52% | 23.24% | 24.91% | 18.92% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $26.8M | $29.9M | $38.5M | $49.7M | $65.1M | |
| Other Inc / (Exp) | -$57.2K | $1.7M | $257.7K | $367.8K | $113.4M | |
| Operating Expenses | $26.8M | $29.9M | $38.5M | $49.7M | $65.1M | |
| Operating Income | $28.3M | $37.2M | $62.2M | $69.1M | $14.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $28.3M | $39M | $62.4M | $69.5M | $128M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $3M | |
| Net Income to Company | $28.3M | $39M | $62.4M | $69.5M | $125.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $28.3M | $39M | $62.4M | $69.5M | $125.1M | |
| Basic EPS (Cont. Ops) | $0.75 | $1.04 | $1.66 | $1.46 | $2.74 | |
| Diluted EPS (Cont. Ops) | $0.75 | $1.04 | $1.66 | $1.46 | $2.35 | |
| Weighted Average Basic Share | $37.6M | $37.6M | $37.6M | $47.6M | $45.6M | |
| Weighted Average Diluted Share | $37.6M | $37.6M | $37.6M | $47.6M | $55.8M | |
| EBITDA | $28.4M | $37.4M | $62.5M | $70M | $16M | |
| EBIT | $28.3M | $37.2M | $62.2M | $69.1M | $14.6M | |
| Revenue (Reported) | $272.2M | $327.3M | $432.9M | $477M | $421.5M | |
| Operating Income (Reported) | $28.3M | $37.2M | $62.2M | $69.1M | $14.6M | |
| Operating Income (Adjusted) | $28.3M | $37.2M | $62.2M | $69.1M | $14.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $77.7M | $111M | $87.7M | $118.6M | |
| Revenue Growth (YoY) | -- | -- | 42.96% | -21% | 35.24% | |
| Cost of Revenues | -- | $56.1M | $82.1M | $70.3M | $96.3M | |
| Gross Profit | -- | $21.6M | $28.9M | $17.4M | $22.4M | |
| Gross Profit Margin | -- | 27.75% | 26.06% | 19.85% | 18.87% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $8.7M | $13.3M | $13.6M | $18.7M | |
| Other Inc / (Exp) | -- | $109.7K | $510 | $148.8M | -$11.1M | |
| Operating Expenses | -- | $8.7M | $13.3M | $13.6M | $18.7M | |
| Operating Income | -- | $12.8M | $15.7M | $3.8M | $3.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | $12.9M | $15.7M | $152.6M | -$7.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $1.7M | -$43.5K | |
| Net Income to Company | -- | -- | $15.7M | $150.8M | -$7.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $12.9M | $15.7M | $150.8M | -$7.3M | |
| Basic EPS (Cont. Ops) | -- | $0.34 | $0.42 | $3.12 | -$0.15 | |
| Diluted EPS (Cont. Ops) | -- | $0.34 | $0.42 | $2.35 | -$0.15 | |
| Weighted Average Basic Share | -- | $37.6M | $37.6M | $48.4M | $48.4M | |
| Weighted Average Diluted Share | -- | $37.6M | $37.6M | $64.8M | $48.4M | |
| EBITDA | -- | $12.9M | $15.9M | $4M | $4.1M | |
| EBIT | -- | $12.8M | $15.7M | $3.8M | $3.7M | |
| Revenue (Reported) | -- | $77.7M | $111M | $87.7M | $118.6M | |
| Operating Income (Reported) | -- | $12.8M | $15.7M | $3.8M | $3.7M | |
| Operating Income (Adjusted) | -- | $12.8M | $15.7M | $3.8M | $3.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $527.6M | $419.7M | $445.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $394.7M | $340M | $366.1M | |
| Gross Profit | -- | -- | $132.9M | $79.7M | $79.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $52.6M | $57.4M | $73.8M | |
| Other Inc / (Exp) | -- | $109.6K | $280.9K | $182.7M | -$26.8M | |
| Operating Expenses | -- | -- | $52.6M | $57.4M | $73.8M | |
| Operating Income | -- | -- | $80.3M | $22.2M | $5.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | $80.6M | $205M | -$20.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $2.4M | -$486.3K | |
| Net Income to Company | -- | -- | -- | $202.6M | -$20.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $80.6M | $202.6M | -$20.4M | |
| Basic EPS (Cont. Ops) | -- | -- | $2.14 | $3.01 | -$0.42 | |
| Diluted EPS (Cont. Ops) | -- | -- | $2.14 | $1.41 | -$0.59 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | $81.1M | $23.2M | $7.9M | |
| EBIT | -- | -- | $80.3M | $22.2M | $5.9M | |
| Revenue (Reported) | -- | -- | $527.6M | $419.7M | $445.7M | |
| Operating Income (Reported) | -- | -- | $80.3M | $22.2M | $5.9M | |
| Operating Income (Adjusted) | -- | -- | $80.3M | $22.2M | $5.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $77.7M | $362M | $304.6M | $328.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $56.1M | $264.7M | $246.5M | $270.8M | |
| Gross Profit | -- | $21.6M | $97.2M | $58.1M | $58.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $8.7M | $38.9M | $46.7M | $55.4M | |
| Other Inc / (Exp) | -- | $109.7K | $264K | $182.6M | $42.5M | |
| Operating Expenses | -- | $8.7M | $38.9M | $46.7M | $55.4M | |
| Operating Income | -- | $12.8M | $58.3M | $11.5M | $2.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | $12.9M | $58.6M | $194.1M | $45.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $2.4M | -$1.1M | |
| Net Income to Company | -- | -- | $58.6M | $191.7M | $46.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $12.9M | $58.6M | $191.7M | $46.2M | |
| Basic EPS (Cont. Ops) | -- | $0.34 | $1.56 | $2.78 | $0.96 | |
| Diluted EPS (Cont. Ops) | -- | $0.34 | $1.56 | $1.18 | $0.79 | |
| Weighted Average Basic Share | -- | $37.6M | $112.7M | $134.1M | $145.1M | |
| Weighted Average Diluted Share | -- | $37.6M | $112.7M | $160.3M | $174.9M | |
| EBITDA | -- | $12.9M | $59M | $12.2M | $4.1M | |
| EBIT | -- | $12.8M | $58.3M | $11.5M | $2.7M | |
| Revenue (Reported) | -- | $77.7M | $362M | $304.6M | $328.9M | |
| Operating Income (Reported) | -- | $12.8M | $58.3M | $11.5M | $2.7M | |
| Operating Income (Adjusted) | -- | $12.8M | $58.3M | $11.5M | $2.7M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $29.2M | $51.5M | $12.2M | $56.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $907.6K | $2.1M | $2M | $1.7M | |
| Inventory | -- | $95.6M | $140M | $180.2M | $182.8M | |
| Prepaid Expenses | -- | $3.4M | $2.9M | $3.8M | $33M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $129.1M | $196.6M | $199.7M | $277.3M | |
| Property Plant And Equipment | -- | $1.2M | $1.6M | $2.4M | $6.5M | |
| Long-Term Investments | -- | -- | -- | $186.1K | $1.4M | |
| Goodwill | -- | -- | -- | -- | $5.7M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | $1.3M | $4.1M | $6.1M | $7.8M | |
| Total Assets | -- | $131.6M | $202.3M | $208.3M | $298.6M | |
| Accounts Payable | -- | $18.8M | $28.7M | $22.1M | $38.7M | |
| Accrued Expenses | -- | $3.8M | $4.5M | $5.5M | $8.4M | |
| Current Portion Of Long-Term Debt | -- | $1.3M | $142.5K | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $97.4M | $135.7M | $148.3M | $125.4M | |
| Long-Term Debt | -- | -- | -- | -- | $71.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $97.4M | $135.7M | $149.3M | $329.8M | |
| Common Stock | -- | -- | $83.6M | $3.7K | $4.8K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | $66.6M | $59M | -$31.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $66.6M | $59M | -$31.2M | |
| Total Liabilities and Equity | -- | $97.4M | $202.3M | $208.3M | $298.6M | |
| Cash and Short Terms | -- | $29.2M | $51.5M | $12.2M | $56.7M | |
| Total Debt | -- | $74.8M | $102.5M | $120.8M | $148.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $19.4M | $81.2M | $25.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $3.9M | $1.9M | $2.9M | |
| Inventory | -- | -- | $200.8M | $132.5M | $175.5M | |
| Prepaid Expenses | -- | -- | $3.6M | $24.6M | $45.7M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | $229.2M | $245.8M | $258.5M | |
| Property Plant And Equipment | -- | -- | $2.1M | $1.4M | $3.3M | |
| Long-Term Investments | -- | -- | -- | $1.1M | $2.4M | |
| Goodwill | -- | -- | -- | -- | $9.3M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $4.3M | $5.3M | $9M | |
| Total Assets | -- | -- | $235.7M | $256.8M | $282.6M | |
| Accounts Payable | -- | -- | $35.8M | $27.3M | $20.8M | |
| Accrued Expenses | -- | -- | $7.9M | $3.6M | $11.7M | |
| Current Portion Of Long-Term Debt | -- | -- | $2.3M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $183.2M | $94.5M | $104.7M | |
| Long-Term Debt | -- | -- | -- | $67.6M | $69.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $183.9M | $222.1M | $262.8M | |
| Common Stock | -- | -- | -- | $4.8K | $4.8K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $34.7M | $19.8M | |
| Total Liabilities and Equity | -- | -- | $183.9M | $256.8M | $282.6M | |
| Cash and Short Terms | -- | -- | $19.4M | $81.2M | $25.8M | |
| Total Debt | -- | -- | $139.5M | $129.8M | $141.8M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $28.3M | $39M | $62.4M | $69.5M | $125.1M | |
| Depreciation & Amoritzation | $83.6K | $182.8K | $358.6K | $881K | $1.3M | |
| Stock-Based Compensation | -- | -- | -- | $1.4M | $7M | |
| Change in Accounts Receivable | -$192.3K | -$563.1K | -$1.2M | -$1.3M | $1.5M | |
| Change in Inventories | -$6.9M | $29.3M | -$12.7M | -$26.7M | $22.2M | |
| Cash From Operations | $24.2M | $71.8M | $58.3M | $34.6M | $28.2M | |
| Capital Expenditures | $328.1K | $805.3K | $404.2K | $171.7K | $162.3K | |
| Cash Acquisitions | -- | -- | -- | -$49K | -$24.3M | |
| Cash From Investing | -$319.9K | -$785.3K | -$394.1K | -$206.9K | -$24.3M | |
| Dividends Paid (Ex Special Dividend) | -$10.4M | -$22.3M | -$33.5M | -$54.2M | -$17.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $193.4M | $207.7M | $295.4M | $190.2M | $144.1M | |
| Long-Term Debt Repaid | -$190.2M | -$217.9M | -$267.7M | -$171.9M | -$105.2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$13M | -$18.9M | -$29.8M | -$37.8M | $14.7M | |
| Cash From Financing | -$20.3M | -$51.4M | -$35.6M | -$73.7M | $40.5M | |
| Beginning Cash (CF) | $6M | $9.6M | $29.2M | $51.5M | $12.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.6M | $19.6M | $22.3M | -$39.3M | $44.4M | |
| Ending Cash (CF) | $9.6M | $29.2M | $51.5M | $12.2M | $56.7M | |
| Levered Free Cash Flow | $23.9M | $71M | $57.9M | $34.4M | $28.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $15.7M | $150.8M | -$7.3M | |
| Depreciation & Amoritzation | -- | -- | $215K | $242.4K | $389K | |
| Stock-Based Compensation | -- | -- | $51.1K | $1.1M | $1.6M | |
| Change in Accounts Receivable | -- | -- | -$2.4M | $8.3M | -$2M | |
| Change in Inventories | -- | -- | -$26.5M | -$16.8M | $9.8M | |
| Cash From Operations | -- | -- | -$18.9M | -$4.8M | $7.2M | |
| Capital Expenditures | -- | -- | $35.7K | -- | $3.1K | |
| Cash Acquisitions | -- | -- | -- | -$2.2M | -- | |
| Cash From Investing | -- | -- | -$35.7K | -$2.1M | $16.7K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | $7.7M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $67M | $416.7K | $18M | |
| Long-Term Debt Repaid | -- | -- | -$38.2M | -$2.2M | -$18.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$37.6M | -$2.8M | -$5.8M | |
| Cash From Financing | -- | -- | -$1.2M | -$4.5M | -$6.3M | |
| Beginning Cash (CF) | -- | -- | $39.5M | $92.7M | $24.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$20.1M | -$11.5M | $902.4K | |
| Ending Cash (CF) | -- | -- | $19.4M | $81.2M | $25.8M | |
| Levered Free Cash Flow | -- | -- | -$19M | -$4.8M | $7.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $202.6M | -$20.4M | |
| Depreciation & Amoritzation | -- | -- | -- | $1M | $2M | |
| Stock-Based Compensation | -- | -- | $1.4M | $6.1M | $5.9M | |
| Change in Accounts Receivable | -- | -- | -- | $3.3M | -$1M | |
| Change in Inventories | -- | -- | -- | $69.1M | -$8.8M | |
| Cash From Operations | -- | -- | -- | $60.4M | -$29.2M | |
| Capital Expenditures | -- | -- | $116.4K | $114.5K | $134.8K | |
| Cash Acquisitions | -- | -- | -$49K | -$2.2M | -$34.9M | |
| Cash From Investing | -- | -- | -- | -$2.2M | -$34.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$51M | -$21M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $165.8M | $87M | |
| Long-Term Debt Repaid | -- | -- | -- | -$160.4M | -$85.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $14.5M | $6.7M | |
| Cash From Financing | -- | -- | -- | $3.6M | $8.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $61.9M | -$55.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $60.3M | -$29.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $58.6M | $191.7M | $46.2M | |
| Depreciation & Amoritzation | -- | -- | $661.5K | $781.6K | $1.4M | |
| Stock-Based Compensation | -- | -- | $1.4M | $6M | $4.9M | |
| Change in Accounts Receivable | -- | -- | -$3.3M | $1.3M | -$1.2M | |
| Change in Inventories | -- | -- | -$47M | $48.8M | $17.8M | |
| Cash From Operations | -- | -- | $19.7M | $45.5M | -$12M | |
| Capital Expenditures | -- | -- | $116.4K | $59.2K | $31.7K | |
| Cash Acquisitions | -- | -- | -$49K | -$2.2M | -$12.7M | |
| Cash From Investing | -- | -- | -$151.6K | -$2.1M | -$12.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$51M | -$17.9M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $138.5M | $114.1M | $57M | |
| Long-Term Debt Repaid | -- | -- | -$101.6M | -$90.1M | -$70M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$37.6M | $14.7M | $6.7M | |
| Cash From Financing | -- | -- | -$51.6M | $25.6M | -$6.2M | |
| Beginning Cash (CF) | -- | -- | $127.5M | $215.9M | $110.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$32.1M | $69M | -$30.9M | |
| Ending Cash (CF) | -- | -- | $95.4M | $284.9M | $79.4M | |
| Levered Free Cash Flow | -- | -- | $19.5M | $45.4M | -$12M | |
Get UHG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UHG
Sector
P/E ratio
3.18x
16.83x
PEG ratio
--
0.22x
P/B ratio
10.30x
1.45x
Price / LTM sales
0.56x
0.71x
Growth Metrics
UHG
Sector
Revenue growth
35.24%
0.14%
Earnings growth
-88.29%
--
Revenue (5-year growth)
--
3.45%
Earnings forecast
--
$0.30
Profitability
UHG
Sector
Profitability FY 2023
$79.7M
$503.7M
Return on invested capital
-13.63%
5.17%
Return on assets
-7.24%
3.13%
Return on equity
-230%
7.63%
Earnings Date
Last Earnings Date
Nov
8
Next Earnings Date
Mar
14
Estimated Next Earnings Date
Feb
7
Balance Sheet
UHG
Sector
Total cash
$25.8M
$157.7M
Short term investments
--
$60.7M
Total assets
$298.6M
$1.7B
Long term debt
$141.8M
$111.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
